Expert Review of Clinical Immunology

Article	Citations
Full consideration of the pollen exposure effect in clinical trial design for pollen-induced allergic rhinitis	97
Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?	95
Pepsin, trypsin, and MUC5B are independent risk factors for hearing impairment in patients with laryngopharyngeal reflux-related chronic secretory otitis media	78
A critical review of dupilumab for adult patients with prurigo nodularis	75
A prospective single-arm study on the efficacy and safety of short-course oral corticosteroids followed by topical corticosteroids in patients with severe chronic rhinosinusitis with nasal polyps	71
The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations	59
Aleukemic variant of T-cell large granular lymphocyte leukemia in patients with rheumatoid arthritis - diagnostically challenging subtype	57
Immunobiology and treatment of cutaneous T-cell lymphoma	46
The therapeutic effect of mRNA vaccines in glioma: a comprehensive review	44
Pioglitazone as a potential modulator in autoimmune diseases: a review on its effects in systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and multiple sclerosis	43
Bimekizumab for the treatment of psoriatic arthritis	38
How could our genetics impact COVID-19 vaccine response?	36
Pan-cancer analysis of the prognostic significance of ACKR2 expression and the related genetic/epigenetic dysregulations	36
Bradford Hill and breast implant illness: no evidence for causal association with breast implants	35
Biomarkers guiding biological therapeutic strategies in chronic rhinosinusitis with nasal polyps: an emerging challenge	33
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease	31
The effect of intense pulsed light combined with topical 0.05% Cyclosporin A eyedrops in the treatment of Sjögren’s syndrome related dry eye	29
Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud’s phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study	28
Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives	28
How to and should we target EBV in MS?	27
Food immunotherapy: current status and future needs	25
IRF1 expression might be a biomarker of CD8+ T cell infiltration in cutaneous melanoma	25
An exercise immune fitness test to unravel mechanisms of Post-Acute Sequelae of COVID-19	24
Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review	24
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment	24

Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives	24
Differential risk of autoimmune disorders in non-traumatic osteonecrosis: clue to pathogenesis	24
Evaluating the use of JAK inhibitors in inflammatory connective tissue diseases in pediatric patients: an update	23
How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?	22
Durability and long-term outcomes of biologic therapies in psoriasis	21
Impact of anti-PD1 immunotherapy and circulating tumor cells on progression-free survival in surgical pancreatic adenocarcinoma: a retrospective cohort study	21
Rare forms of inflammatory myopathies – part I, generalized forms	21
Emergence of an adaptive immune paradigm to explain celiac disease: a perspective on new evidence and implications for future interventions and diagnosis	21
Current treatment options and long-term outcomes in patients with eosinophilic esophagitis	19
Gut immune homeostasis: the immunomodulatory role of Bacillus clausii, from basic to clinical evidence	18
Direct economic burden 1 year postoperation in Chinese adult patients with chronic rhinosinusitis with nasal polyps	18
Transcriptional regulation of B cell class-switch recombination: the role in development of noninfectious complications	18
Classification and management strategies for paediatric chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis	18
Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults	18
Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors	17
Neurological adverse effects of chimeric antigen receptor T-cell therapy	17
T-lymphocyte depleted transplants for inborn errors of immunity	17
Pathophysiology and management of Staphylococcus aureus in nasal polyp disease	17
Challenges in uncontrolled asthma in pediatrics: important considerations for the clinician	16
Chronic obstructive pulmonary disease, biological agents and small molecules: where do we stand?	16
IL-17A in psoriatic arthritis: mechanistic insights, clinical implications, and advances in therapeutic strategies	16
Eradicating measurable residual disease via immunotherapy to cure acute lymphoblastic leukemia: current status and future directions	16
Inflammatory myopathy in adults, health-related quality of life, and wellbeing: a round trip between immune disease and wellness	16
An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia	16
Recent insights into comorbidities in atopic dermatitis	16
The role of interleukins in pathogenesis and prognosis of atrial fibrillation	15
The functional role and the clinical application of periostin in chronic rhinosinusitis	15
Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events	15
CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity	15
Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management	15
Personalization of therapy for patients with eosinophilic esophagitis	15
Diagnostic accuracy of QuantiFERON-TB gold plus with chemiluminescence immunoassay: a systematic review and meta-analysis	14
Glucocorticoid in systemic lupus erythematosus: the art beyond science	14
Advances in tumor immunotherapy targeting macrophages	14
Peanut allergy: risk factors, immune mechanisms, and best practices for oral immunotherapy success	14
Patient-centered approaches for patients with systemic autoimmune rheumatic diseases: development and evolution	14
Advancements in immunotherapy for advanced esophageal squamous cell carcinoma: a comprehensive review of current strategies and future directions	14
Temporal trends in anaphylaxis ED visits over the last decade and the effect of COVID-19 pandemic on these trends	13
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis	13
Harnessing the power of AI-based models to accelerate drug discovery against immune diseases	13
Updates in toxicities associated with immune checkpoint inhibitors	13
Insights into the immunological links between dietary habits and asthma	13
Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency	13
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation	13
Toward a personalized therapy of still’s disease based on immunologic endotypes: a narrative review	13
At the cutting-edge: what’s the latest in imaging to diagnose Sjögren’s disease?	13
Monoclonal antibodies in diabetic retinopathy	12
Induction of aquaporins by plasma of patients with systemic lupus erythematosus	12
New advances on the interaction between internal and external factors in the tumor microenvironment of solid tumors	12
How does sleep influence asthma through immunity?	12

Immunology and targeted therapy in Castleman disease	12
Guidance for stem cell therapy for juvenile systemic sclerosis patients	12
Comparing available JAK inhibitors for treating patients with psoriasis	12
Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis	12
What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?	12
Definition of severity and treatment response in chronic rhinosinusitis with nasal polyps: a Delphi study among French experts	12
Pediatric IgG4-related disease: a descriptive review	12
The role of serological biomarkers in the diagnosis and management of autoimmune pancreatitis	11
Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis – a meta-analysis of randomized clinical trials	11
Basophil activation test in the food allergy clinic: its current use and future applications	11
The interaction between innate immunity and oral microbiota in oral diseases	11
Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy	11
Current approaches for diagnosis of subclinical pulmonary tuberculosis, clinical implications and future perspectives: a scoping review	11
Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies	11
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine	11
Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics	11
B cell depletion and inhibition in systemic lupus erythematosus	11
Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors	10
Individual differences in response to dust-mite-allergen specific immunotherapy in allergic rhinitis: a meta-analysis of randomized controlled trials	10
Model-based computational precision medicine to develop combination therapies for autoimmune diseases	10
Transglutaminase 2 in chronic inflammation and fibrosis – a potential novel therapy for stricturing Crohn’s disease	10
Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease	10
Phosphoinositide-3-kinase δ as an immune check-pathway in cancer Immunology. Therapeutic prospects	10
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience	10
The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation	10
Sequential immunotherapy for alopecia areata: phase-driven immune rebalancing	10
The relationship between interleukin 17A rs2275913 gene polymorphism and circulating IL17A levels and disease activity and severity in Egyptian rheumatoid arthritis patients	10
Dysautonomia in systemic lupus erythematosus: when to suspect and how to investigate	10
A review of disease burden and clinical management for generalized pustular psoriasis in China	10
Tofacitinib for the treatment of active ankylosing spondylitis in adults	10
Update on virus-induced asthma exacerbations	10
An update on VEXAS syndrome	10
Vascular endothelial dysfunction in pediatric rheumatic diseases: a systematic review and meta-analysis	10
Systemic therapy in juvenile localized scleroderma	9
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications	9
Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies	9
An evaluation of anifrolumab for use in adults with systemic lupus erythematosus	9
Epstein–Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge	9
The clinical role of anakinra in the armamentarium against familial Mediterranean fever	9
Early diagnosis of systemic sclerosis, where do we stand today?	9
The (apparent) antibody paradox in COVID-19	9
Role of tight junction proteins in shaping the immune milieu of malignancies	9
Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives	9
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons	9
The role of PCSK9 in inflammation, immunity, and autoimmune diseases	8
Biomarkers for systemic lupus erythematosus – a focus on organ damage	8
Multiple sclerosis-like manifestations in systemic autoimmune and inflammatory disorders: an update	8
Comorbid allergic rhinitis and asthma: important clinical considerations	8
Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A critical review of the literature	8
Toward precision in psoriatic arthritis: addressing the challenge of difficult-to-treat disease	8
A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease	8
AQP9 weakens the cytotoxicity of CD8 + T cells in colon adenocarcinoma by boosting M2 polarization of macrophages under hypoxia conditions	8
Considerations for managing elderly patients with atopic dermatitis	8
Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective	8
Evaluating the role of lung ultrasound in the diagnosis of rheumatoid arthritis-interstitial lung disease	8
Anti-angiotensin 2 receptor 1 antibody (anti-AT1R) and anti-endothelin receptor type a (anti-ETAR) as biomarkers of endothelial dysfunction in systemic sclerosis (SSc) patients	8
Cross-talk between immune cells and tumor cells in non-Hodgkin lymphomas arising in common variable immunodeficiency	8
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population	8
The suitability of treating atopic dermatitis with Janus kinase inhibitors	8
Lack of association between TNFA and TNFB polymorphisms and the risk of multiple sclerosis: a meta-analysis from 37 studies	8
Enthesitis-related arthritis and spondylarthritis: the same disease or disparate entities?	8
Response to letter to the editor: Bradford Hill and breast implant illness: evidence for a causal association with breast implants	8
The emerging role of IL-23 in asthma and its clinical implications	8
Mechanisms and therapeutic potential of epithelial-immune crosstalk in airway inflammation	8
Management and treatment optimization of patients with mild to moderate ulcerative colitis	8
Late effects following hematopoietic cell transplantation for severe combined immunodeficiency: critical factors and therapeutic options	8
Potential interactions between STING pathway and the complement system in immune regulation	8
Cytokine alterations in psoriasis: an updated review	8
Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults	8
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges	8
Clinical and immunologic implication of neo-osteogenesis in chronic rhinosinusitis	8
Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis	7
TBXAS1 deficiency: a novel monogenic cause of chronic nonbacterial osteomyelitis responsive to COX inhibitors	7
Development of a method of nasal secretions sampling for local nasal inflammation studies	7
Decoding T and B cell dynamics in inborn errors of immunity: insights into immune dysfunction	7
Inflammation resolution and specialized pro-resolving lipid mediators in chronic rhinosinusitis	7
Is post-COVID syndrome an autoimmune disease?	7
Unmet needs in the management of giant cell arteritis and polymyalgia rheumatica	7
The burden of mental health issues in Behçet’s disease: implications for patient quality of life	7
The clinical management of adult patients with Familial Mediterranean fever	7

Colchicine: protection of the brain beyond the heart?	7
Resveratrol: immunological activity and possible application in children and adolescents with allergic rhinitis	7
Comparative efficacy of systemic treatments for atopic dermatitis in adults	7
The pathophysiology of MASLD: an immunometabolic perspective	7
The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review	7
Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review	7
COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?	7
Thyroid eye disease in the biologic era: a 40-year paradigm shift in nonsurgical therapeutic strategies	7
Recent issues in JAK inhibitor safety: perspective for the clinician	7
Immunology of heart failure with preserved ejection fraction	7
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus	6
A review of current biomarkers in chronic rhinosinusitis with or without nasal polyps	6
Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps	6
Growth differentiation factor-15 as an emerging biomarker for identifying myositis	6
Re-envisioning clinical trial design in systemic sclerosis	6
Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease	6
Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis	6
An evaluation of the recently approved drugs for treating atopic dermatitis in the context of their safety and efficacy: a systematic review and meta-analysis	6
Unmasking cancer’s silent saboteurs: T regulatory cells as therapeutic targets in immunotherapy	6
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease	6
What is the full potential of baricitinib in treating patients with COVID-19?	6
Genetic syndromes and autoimmunity: what do we know? Focus on Down and Turner syndrome	6
Telemedicine beyond the pandemic: challenges in the pediatric immunology clinic	6
Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimens	6
Correction	6
Central nervous system immunological complications of immunotherapy in pediatrics	6
Olfactory dysfunction in chronic rhinosinusitis: insights into the underlying mechanisms and treatments	6
IL-10: the master immunomodulatory cytokine in allergen immunotherapy	6
Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis	6
Managing acute COVID-19 in immunocompromised pediatric patients	6
Machine learning approaches to improve disease management of patients with rheumatoid arthritis: review and future directions	6
Innovative surgical approaches for chronic rhinitis: nasal neurectomy mechanisms, techniques, and clinical outcomes	5
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy	5
Neuro-ophthalmic challenges and multi-morbidity in vasculitis among the older adults	5
Exploring treatment options for pediatric refractory chronic urticaria	5
Single-cell RNA sequencing: an emerging tool revealing dysregulated innate and adaptive immune response at single cell level in Kawasaki disease	5
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus	5
The oft-overlooked cardiovascular complications of inflammatory bowel disease	5
Recent insights into the impacts of COVID-19 on pediatric asthma	5
Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies – real-world data from the IG TATRY study	5
Biologics for chronic spontaneous urticaria: toward a personalized treatment	5
Avacopan for the treatment of ANCA-associated vasculitis: an update	5
Linking stress and inflammation – is there a missing piece in the puzzle?	5
Epithelial cell dysfunction in chronic rhinosinusitis: the epithelial–mesenchymal transition	5
A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis	5
Clinical guide to eosinophilic fasciitis: straddling dermatology and rheumatology	5
Personalizing therapy selection in inflammatory bowel disease	5
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours	5
The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders	5
Comparing treatment options for large vessel vasculitis	5
Update on the pathophysiology and treatment of diabetic kidney disease: a narrative review	5
Conventional and new immunotherapies for immune system dysregulation in postpartum mood disorders: comparisons to immune system dysregulations in bipolar disorder, major depression, and postpartum aut	5
Probiotics in asthma management: fiction or truth?	5
What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?	5
Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy	5
Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial	5
Ruxolitinib cream for the short-term treatment of mild-moderate atopic dermatitis	4
Do JAK inhibitors have a realistic future in treating Crohn’s disease?	4
Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies	4
Breast implant illness: scientific evidence of its existence	4
Translational impact of omics studies in alopecia areata: recent advances and future perspectives	4
Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis	4
Topical roflumilast for the treatment of psoriasis	4
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making	4
Secukinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients aged six years and older	4
An update on biologic treatments for neuromyelitis optica spectrum disorder	4
Chronic rhinosinusitis disease control: a review of the history and the evidence	4
Exploring the relationship between house dust mites and asthma	4
Diagnostic methods and strategies for autoimmune bullous diseases	4
Management of severe asthma in children: current insights and future directions	4
Why do drug treatments fail in Sjögren’s disease? Considerations for treatment, trial design and interpretation of clinical efficacy	4
EVA1A facilitates glycolysis in esophageal squamous cell carcinoma to boost PLAU histone lactylation and dampen CD8 + T cell activity	4
The role of nasal cytology in the diagnosis and treatment of Allergic rhinitis	4
Upadacitinib for moderate-to-severe atopic dermatitis, in adults and adolescents 12 years and older: review of international and Japanese populations	4
The complex relationship between large granular lymphocyte leukemia and rheumatic disease	4
Combination immunotherapy for pancreatic cancer: challenges and future considerations	4
Precision medicine in chronic rhinosinusitis – using endotype and endotype-driven therapeutic options	4
Gut inflammation in CVID: causes and consequences	4
IgG4-related disease: advances in pathophysiology and treatment	4
Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA)	4
Diagnosis and management of systemic sclerosis-related calcinosis	4
Association between inactivated COVID-19 vaccine and semen quality among males recovered from omicron infection: a retrospective cohort study	4
Prognostic factors for post-operative outcomes in chronic rhinosinusitis with nasal polyps: a systematic review	4
New therapeutic concepts against ischemia-reperfusion injury in organ transplantation	4
Machine learning method for the cellular phenotyping of nasal polyps from multicentre tissue scans	4
Anoikis and SPP1 in idiopathic pulmonary fibrosis: integrating bioinformatics, cell, and animal studies to explore prognostic biomarkers and PI3K/AKT signaling regulation	4
Causal role of immune cells in chronic obstructive pulmonary disease: Mendelian randomization study	4
Behçet disease: epidemiology, classification criteria and treatment modalities	4
Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression	4
Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis	4
Periostin as a biomarker of severity and mortality in COVID-19 patients	4
Preventing fibrosis in IBD: update on immune pathways and clinical strategies	4
Connecting salivary gland inflammation to specific symptoms in Sjögren’s disease	4
New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis	4
A review of berotralstat for the treatment of hereditary angioedema	4